SB
ARRY

Suntrust Banks’s Array Biopharma Inc ARRY Stock Holding History

Suntrust Banks’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-16,820
Closed -$78K – 1785
2014
Q1 		$78K Buy
16,820
+6,800
+68% +$34.2K ﹤0.01% 1864
2013
Q4 		$50K Sell
10,020
-2,500
-20% -$13.6K ﹤0.01% 1809
2013
Q3 		$77K Buy
12,520
+2,406
+24% +$14.3K ﹤0.01% 1763
2013
Q2 		$45K Buy
+10,114
New +$54.4K ﹤0.01% 1688

Other funds holding ARRY

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Suntrust Banks's ARRY Position: Q2 2014 in Review

Suntrust Banks sold out of Array Biopharma Inc (ARRY) in Q2 2014, closing a stake of 16,820 shares — an estimated $78K sold.

Suntrust Banks first reported a position in ARRY in Q2 2013 and held it in 4 quarters. The position peaked at $78K in Q1 2014. 129 funds tracked by Wall St. Rank hold ARRY as of Q2 2014.

  • Suntrust Banks reported no remaining Array Biopharma Inc position as of Q2 2014 after selling out during the quarter.
  • Suntrust Banks sold 16,820 Array Biopharma Inc shares in Q2 2014, an estimated $78K.
  • Suntrust Banks first reported a position in Array Biopharma Inc in Q2 2013 and held it in 4 quarters.
  • Suntrust Banks's Array Biopharma Inc position peaked at $78K in Q1 2014.
  • 129 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2014.

Based on Suntrust Banks's 13F filing for Q2 2014, filed 14 Aug 2014.